Bolivia, Plurinational State of vs Sri Lanka: Tuberculosis treatment success rate
Bolivia, Plurinational State of
79.0%
in 2023
Sri Lanka
80.0%
in 2023
Bolivia, Plurinational State of rank
126th
Sri Lanka rank
125th
Tuberculosis treatment success rate over time
- Bolivia, Plurinational State of
- Sri Lanka
How they compare
Sri Lanka currently reports 80.0% against 79.0% in Bolivia, Plurinational State of, a difference of 1.0%.
The two have swapped places 6 times across 30 shared years of data; in 1994 it was Sri Lanka ahead.
Bolivia, Plurinational State of ranks 126th and Sri Lanka ranks 125th of 206 countries.
Sri Lanka has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Bolivia, Plurinational State of | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 68.7% | 77.8% | 9.2% | Sri Lanka |
| 2000s | 79.6% | 84.1% | 4.5% | Sri Lanka |
| 2010s | 83.7% | 85.6% | 1.9% | Sri Lanka |
| 2020s | 79.5% | 80.5% | 1.0% | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Bolivia, Plurinational State of or Sri Lanka?
- Sri Lanka, at 80.0% against 79.0% in Bolivia, Plurinational State of as of 2023.
- What is the difference in tuberculosis treatment success rate between Bolivia, Plurinational State of and Sri Lanka?
- 1.0%, with Sri Lanka ahead.
- How many years of comparable data are there for Bolivia, Plurinational State of and Sri Lanka?
- 30 years are reported by both, from 1994 to 2023.
- How do Bolivia, Plurinational State of and Sri Lanka rank globally for tuberculosis treatment success rate?
- Bolivia, Plurinational State of ranks 126th and Sri Lanka ranks 125th of 206 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment success rate among new and relapse cases.